ROIVANT SCIENCES LTD (ROIV) Forecast, Price Target & Analyst Ratings

NASDAQ:ROIV • BMG762791017

Current stock price

29.83 USD
+0.64 (+2.19%)
At close:
29.88 USD
+0.05 (+0.17%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ROIVANT SCIENCES LTD (ROIV).

Forecast Snapshot

Consensus Price Target

Price Target
$33.66
+ 12.84% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
N/A
Period
Q4 / 2026
EPS Estimate
-$0.36
Revenue Estimate
3.896M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
86.32%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$33.66
Upside
+ 12.84%
From current price of $29.83 to mean target of $33.66, Based on 19 analyst forecasts
Low
$21.21
Median
$35.70
High
$40.95

Price Target Revisions

1 Month
2.63%
3 Months
25.97%

Price Target Summary

19 Wall Street analysts provided a forecast for the next 12 months for ROIV. The average price target is 33.66 USD. This implies a price increase of 12.84% is expected in the next year compared to the current price of 29.83.
The average price target has been revised upward by 25.97% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

ROIV Current Analyst RatingROIV Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8

Analyst Ratings History

ROIV Historical Analyst RatingsROIV Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15

Analyst Ratings Consensus

ChartMill Buy Consensus
86.32%
ROIV was analyzed by 19 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about ROIV.
In the previous month the buy percentage consensus was at a similar level.
ROIV was analyzed by 19 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-04-16Piper SandlerMaintains Overweight -> Overweight
2026-03-04HC Wainwright & Co.Maintains Buy -> Buy
2026-02-10CitigroupMaintains Buy -> Buy
2026-02-10HC Wainwright & Co.Maintains Buy -> Buy
2026-02-09GuggenheimMaintains Buy -> Buy
2025-12-15Leerink PartnersMaintains Outperform -> Outperform
2025-12-15Goldman SachsMaintains Buy -> Buy
2025-12-12HC Wainwright & Co.Maintains Buy -> Buy
2025-11-11CitigroupMaintains Buy -> Buy
2025-10-29CitigroupMaintains Buy -> Buy
2025-09-18Leerink PartnersMaintains Outperform -> Outperform
2025-09-18GuggenheimMaintains Buy -> Buy
2025-09-18JP MorganMaintains Overweight -> Overweight
2025-09-18Goldman SachsMaintains Buy -> Buy
2025-09-18B of A SecuritiesMaintains Neutral -> Neutral
2025-09-18JefferiesMaintains Buy -> Buy
2025-09-18HC Wainwright & Co.Maintains Buy -> Buy
2025-09-02CitigroupInitiate Buy
2025-06-18HC Wainwright & Co.Reiterate Buy -> Buy
2025-05-28HC Wainwright & Co.Reiterate Buy -> Buy
2025-04-21HC Wainwright & Co.Reiterate Buy -> Buy
2025-02-11HC Wainwright & Co.Reiterate Buy -> Buy
2024-11-13HC Wainwright & Co.Reiterate Buy -> Buy
2024-09-19Cantor FitzgeraldReiterate Overweight
2024-09-19HC Wainwright & Co.Reiterate Buy -> Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
N/A
Period
Q4 / 2026
EPS Estimate
-$0.36
Revenue Estimate
3.896M
Revenue Q2Q
-48.53%
EPS Q2Q
-24.82%
Number of Analysts
12

Next Earnings Revisions

Revenue (1 Month)
-8.48%
Revenue (3 Months)
-43.02%
EPS (1 Month)
2.47%
EPS (3 Months)
5.00%

Next Earnings Summary

The next earnings revenue estimate has been revised downward by 43.02% in the past 3 months. Downward revisions are a negative sign and indicate that analysts are more pessimistic about the next earnings compared to 3 months ago.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
ROIV revenue by date.ROIV revenue by date.
61.28M
10.83%		32.713M
-46.62%		29.053M
-11.19%		9.953M
-65.74%		84.064M
744.61%		566.02M
573.32%		1.896B
234.97%		3.176B
67.51%		4.508B
41.94%		6.19B
37.31%		7.354B
18.80%
EBITDA
YoY % growth
ROIV ebitda by date.ROIV ebitda by date.
-1.156B
12.87%		-802.892M
30.57%		-1.1B
-36.96%		-1.245B
-13.23%		-1.291B
-3.69%		-1.076B
16.66%		N/AN/AN/AN/AN/A
EBIT
YoY % growth
ROIV ebit by date.ROIV ebit by date.
-1.175B
13.04%		-824.928M
29.81%		-1.114B
-35.00%		-1.298B
-16.59%		-1.329B
-2.38%		-963.533M
27.52%		-190.054M
80.28%		780.98M
510.92%		1.655B
111.91%		2.916B
76.19%		3.647B
25.07%
Operating Margin
ROIV operating margin by date.ROIV operating margin by date.
-1,917.95%-2,521.71%-3,833.27%-13,045.97%-1,581.37%-170.23%-10.02%24.59%36.71%47.11%49.59%
EPS
YoY % growth
ROIV eps by date.ROIV eps by date.
-1.59
-8.78%		-1.27
20.13%		-0.25
80.31%		-1.30
-418.84%		-1.46
-12.60%		-1.31
10.24%		0.59
144.74%		1.44
146.09%		2.57
78.09%		3.83
48.81%		4.71
23.20%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		-0.36
-24.82%		-0.37
-12.82%		-0.41
-142.10%		-0.39
-2.54%		-0.39
-8.96%
Revenue
Q2Q % growth		3.896M
-48.53%		3.276M
50.97%		3.276M
108.53%		18.867M
843.82%		19.941M
411.83%
EBITDA
Q2Q % growth		-313.496M
-15.73%		-323.157M
-13.86%		-328.394M
-7.95%		-295.106M
12.29%		N/A
EBIT
Q2Q % growth		-315.899M
-10.86%		-307.189M
-7.82%		-320.395M
-4.62%		-311.275M
8.22%		-367.608M
-16.37%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

ROIV Yearly Revenue VS EstimatesROIV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 2B 4B 6B
ROIV Yearly EPS VS EstimatesROIV Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 2 4

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
-73.73%
EPS Next 5 Year
50.70%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
93.20%
Revenue Next 5 Year
101.24%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
-1.40%
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

ROIVANT SCIENCES LTD / ROIV Forecast FAQ

What is the average price target for ROIVANT SCIENCES LTD (ROIV) stock?

19 analysts have analysed ROIV and the average price target is 33.66 USD. This implies a price increase of 12.84% is expected in the next year compared to the current price of 29.83.

Can you provide the consensus estimates for ROIVANT SCIENCES LTD next earnings?

The consensus EPS estimate for the next earnings of ROIVANT SCIENCES LTD (ROIV) is -0.36 USD and the consensus revenue estimate is 3.90M USD.

What is the consensus rating for ROIVANT SCIENCES LTD (ROIV) stock?

The consensus rating for ROIVANT SCIENCES LTD (ROIV) is 86.3158 / 100 . This indicates that analysts generally have a positive outlook on the stock.